Atai Life Sciences Pre-Paid Expenses 2020-2024 | ATAI

Atai Life Sciences pre-paid expenses from 2020 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
Atai Life Sciences Annual Pre-Paid Expenses
(Millions of US $)
2024 $8
2023 $6
2022 $14
2021 $12
2020 $2
2019 $1
Atai Life Sciences Quarterly Pre-Paid Expenses
(Millions of US $)
2024-12-31 $8
2024-09-30 $7
2024-06-30 $5
2024-03-31 $6
2023-12-31 $6
2023-09-30 $7
2023-06-30 $6
2023-03-31 $9
2022-12-31 $14
2022-09-30 $13
2022-06-30 $11
2022-03-31 $13
2021-12-31 $12
2021-09-30 $12
2021-06-30 $4
2021-03-31 $4
2020-12-31 $2
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.294B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.282B 18.36
DaVita (DVA) United States $11.202B 14.29
Encompass Health (EHC) United States $10.408B 23.33
Chemed (CHE) United States $8.501B 27.28
Option Care Health (OPCH) United States $5.259B 25.21
Elanco Animal Health (ELAN) United States $4.190B 9.27
RadNet (RDNT) United States $3.686B 79.02
Amedisys (AMED) United States $3.011B 21.29
LifeStance Health (LFST) United States $2.576B 0.00
Addus HomeCare (ADUS) United States $1.840B 21.32
Astrana Health (ASTH) United States $1.573B 35.26
U.S Physical Therapy (USPH) United States $1.025B 26.14
Pennant (PNTG) United States $0.907B 36.29
Aveanna Healthcare Holdings (AVAH) United States $0.886B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00